Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 9, 2015, Pages 3231-3244

  Isidori, Andrea M ^a   Sbardella, Emilia ^a   Zatelli, Maria Chiara ^b   Boschetti, Mara ^c   Vitale, Giovanni ^d   Colao, Annamaria ^e   Pivonello, Rosario ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; 6 FLUORODOPA F 18; FLUORODEOXYGLUCOSE F 18; GALLIUM DOTATATE GA 68; GALLIUM DOTATOC GA 68; PENTETREOTIDE IN 111; TRACER; UNCLASSIFIED DRUG;

COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ECTOPIC CUSHING SYNDROME; ECTOPIC ORGAN; HORMONE DETERMINATION; HUMAN; INTERMETHOD COMPARISON; MOLECULAR IMAGING; NEUROBLASTOMA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; THYROID MEDULLARY CARCINOMA; TUMOR LOCALIZATION; NUCLEAR MEDICINE; PROCEDURES; REPRODUCIBILITY;

CUSHING SYNDROME; DIAGNOSTIC IMAGING; HUMANS; NUCLEAR MEDICINE; REPRODUCIBILITY OF RESULTS;

EID: 84941730293     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/JC.2015-1589     Document Type: Review

References (147)

1. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90:4955-4962.
2. Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab. 2006;91:371-377.
3. Wajchenberg BL, Mendonca BB, Liberman B, et al. Ectopic adrenocorticotropic hormone syndrome. Endocr Rev. 1994;15:752-787.
4. de Herder WW, Lamberts SW. Tumor localization-the ectopic ACTH syndrome. J Clin Endocrinol Metab. 1999;84:1184-1185.
5. Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, van Heerden JA. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg. 2001;25:934-940.
6. Zemskova MS, Gundabolu B, Sinaii N, et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab. 2010;95:1207-1219.
7. Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, et al. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer. 2011;117:4381-4389.
8. BoscaroM,Arnaldi G. Approach to the patient with possible Cushing's syndrome. J Clin Endocrinol Metab. 2009;94:3121-3131.
9. Isidori AM, Lenzi A. Ectopic ACTH syndrome. Arq Bras Endocrinol Metabol. 2007;51:1217-1225.
10. Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol. 2009;6:419-428.
11. Vinik AI, Woltering EA, Warner RR, et al. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas. 2010;39:713-734.
12. Singh S, Dey C, Kennecke H, et al. Consensus recommendations for the diagnosis and management of pancreatic neuroendocrine tumors: guidelines from a Canadian National Expert Group [published online November 4, 2014]. Ann Surg Oncol. doi: 10.1245/s10434-014-4145-0.
13. Jensen RT, Cadiot G, Brandi ML, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95:98-119.
14. Falconi M, Bartsch DK, Eriksson B, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 2012;95:120-134.
15. Phan AT, Oberg K, Choi J, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: welldifferentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010;39:784-798.
16. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526-1540.
17. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010; 340:c221.
18. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873-890.
19. Nikolaou A, Thomas D, Kampanellou C, et al. The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center. J Endocrinol Invest. 2010;33:794-799.
20. Zhang DM, Xue HD, Duan L, Li J, Li NS, Jin ZY. A small solitary pulmonary nodule discovered by (18)F-fluorodeoxyglucose positron emission tomography and CT: rare infection instead of rare tumor. Chin Med Sci J. 2013;27:249-252.
21. Zangeneh F, Young WF Jr, Lloyd RV, Chiang M, Kurczynski E, Zangeneh F. Cushing's syndrome due to ectopic production of corticotropin-releasing hormone in an infant with ganglioneuroblastoma. Endocr Pract. 2003;9:394-399.
22. Yu J, Koch CA, Patsalides A, et al. Ectopic Cushing's syndrome caused by an esthesioneuroblastoma. Endocr Pract. 2004;10:119-124.
23. Xu H, Zhang M, Zhai G, Zhang M, Ning G, Li B. The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors. Endocrine. 2009;36:385-391.
24. Willhauck MJ, Pöpperl G, Rachinger W, Giese A, Auernhammer CJ, Spitzweg C. An unusual case of ectopic ACTH syndrome. Exp Clin Endocrinol Diabetes. 2012;120:63-67.
25. Wahlberg J, Ekman B. Atypical or typical adrenocorticotropic hormone-producing pulmonary carcinoids and the usefulness of 11C-5-hydroxytryptophan positron emission tomography: two case reports. J Med Case Rep. 2013;7:80.
26. Venkitaraman B, Karunanithi S, Kumar A, Bal C, Ammini AC, Kumar R. 68Ga-DOTATOC PET-CT in the localization of source of ectopic ACTH in patients with ectopic ACTH-dependent Cushing's syndrome. Clin Imaging. 2014;38:208-211.
27. Veit JA, Boehm B, Luster M, et al. Detection of paranasal ectopic adrenocorticotropic hormone-secreting pituitary adenoma by Ga-68-DOTANOCpositron-emission tomography-computed tomography. Laryngoscope. 2013;123:1132-1135.
28. Tsagarakis S, Christoforaki M, Giannopoulou H, et al. A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome. J Clin Endocrinol Metab. 2003;88:4754-4758.
29. Treglia G, Salomone E, Petrone G, Giaccari A, Rindi G, Rufini V. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT. Clin Nucl Med. 2013;38:e306-e308.
30. Tani Y, Sugiyama T, Hirooka S, Izumiyama H, Hirata Y. Ectopic ACTH syndrome caused by bronchial carcinoid tumor indistinguishable from Cushing's disease. Endocr J. 2010;57:679-686.
31. Sugiyama M, Sugiyama T, Yamaguchi M, et al. Successful localization of ectopic ACTH-secreting bronchial carcinoid by selective pulmonary arterial sampling. Endocr J. 2010;57:959-964.
32. Mondello S, Fodale V, Cannav S, et al. Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report. ScientificWorldJournal. 2008;8:138-144.
33. Sofka S, Jackson T. Bronchopulmonary carcinoid presenting as dexamethasone suppressible Cushing's syndrome. W V Med J. 2013;109:26-28.
34. Singer J, Werner F, Koch CA, et al. Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes. 2010;118: 524-529.
35. Silye R, Rieger R, Topakian R, Dunzinger A, Aigner RM, Pichler R. Cushing syndrome due to ectopic adrenocorticotropin secretion by oncocytic thyroid nodule. J Clin Endocrinol Metab. 2012;97: 39-40.
36. Sharma ST, Raff H, Nieman LK. Prolactin as a marker of successful catheterization during IPSS in patients with ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab. 2011;96:3687-3694.
37. Shahani S, Nudelman RJ, Nalini R, Kim HS, Samson SL. Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature. Diagn Pathol. 2010;5:56.
38. Schalin-Jäntti C, Asa SL, Arola J, Sane T. Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH. Endocr Pathol. 2013;24:25-29.
39. Salgado LR, Fragoso MC, Knoepfelmacher M, et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol. 2006;155:725-733.
40. Ruggeri RM, Ferra F, Campenn A, et al. Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone- secreting adrenal phaeochromocytoma: review of the literature and report of a case. Eur J Histochem. 2009;53:1-6.
41. Rodrigues P, Castedo JL, Damasceno M, Carvalho D. Ectopic Cushing's syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide. Arq Bras Endocrinol Metabol. 2012;56:461-464.
42. Rod A, Voicu M, Chiche L, et al. Cushing's syndrome associated with a nested stromal epithelial tumor of the liver: hormonal, immunohistochemical, and molecular studies. Eur J Endocrinol. 2009;161:805-810.
43. Pivonello R, Ferone D, Lamberts SW, Colao A. Cabergoline plus lanreotide for ectopic Cushing's syndrome. N Engl J Med. 2005; 352:2457-2458.
44. Perakakis N, Laubner K, Keck T, et al. Ectopic ACTH-syndrome due to a neuroendocrine tumour of the appendix. Exp Clin Endocrinol Diabetes. 2011;119:525-529.
45. Parenti G, Nassi R, Silvestri S, et al. Multi-step approach in a complex case of Cushing's syndrome and medullary thyroid carcinoma. J Endocrinol Invest. 2006;29:177-181.
46. Bhatia PD, Fung K, Edmonds M, Driedger AA, Malthaner RA. A case of bronchopulmonary carcinoid tumor: the role of octreotide scanning in localization of an ectopic source ofACTH.JHospMed. 2006;1:312-316.
47. Özkan ZG, Kuyumcu S, Balköse D, et al. The value of somatostatin receptor imaging with In-111 octreotide and/or Ga-68 DOTATATE in localizing ectopic ACTH producing tumors. Mol Imaging Radionucl Ther. 2013;22:49-55.
48. Otsuka F, Miyoshi T, Murakami K, et al. An extra-adrenal abdominal pheochromocytoma causing ectopic ACTH syndrome. Am J Hypertens. 2005;18:1364-1368.
49. Oosterhuis JK, van den Berg G, Monteban-Kooistra WE, et al. Life-threatening Pneumocystis jiroveci pneumonia following treatment of severe Cushing's syndrome. Neth J Med. 2007;65:215-217.
50. Netea-Maier RT, Nieuwlaat WA, Sweep CG, Wesseling P, Massuger L, Hermus AR. Virilization due to ovarian androgen hypersecretion in a patient with ectopic adrenocorticotrophic hormone secretion caused by a carcinoid tumour: case report. Hum Reprod. 2006;21:2601-2605.
51. Al Brahim NY, Rambaldini G, Ezzat S, Asa SL. Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncology. Endocr Pathol. 2007;18:37-41.
52. Moreno-Fernández J, Gutiérrez-Alcántara C, Gálvez MorenoMA, Jiménez-Reina L, Castaño JP, Benito-López P. Corticotrophin-dependent Cushing syndrome due to sacrococcygeal teratoma detected by [18F]fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab. 2008;93:3282-3283.
53. More J, Young J, Reznik Y, et al. Ectopic ACTH syndrome in children and adolescents. J Clin Endocrinol Metab. 2011;96:1213-1222.
54. Molina Garrido MJ, Guillén Ponce C, Maciá Escalante S, Pons Sanz V, Carrato Mena A. Cushing's paraneoplastic syndrome as first manifestation of an adenocarcinoma of unknown origin. Clin Transl Oncol. 2006;8:621-623.
55. Miehle K, Tannapfel A, Lamesch P, et al. Pancreatic neuroendo crine tumor with ectopic adrenocorticotropin production upon second recurrence. J Clin Endocrinol Metab. 2004;89:3731-3736.
56. Meinardi JR, van den Berg G, Wolffenbuttel BH, Kema IP, Dullaart RP. Cyclical Cushing's syndrome due to an atypical thymic carcinoid. Neth J Med. 2006;64:23-27.
57. McDermott JH, Thabit H, Hickey N, et al. ACTH-secreting bronchial carcinoid: a diagnostic and therapeutic challenge. Ir JMedSci. 2008;177:269-272.
58. Matarazzo P, Tuli G, Tessaris D, et al. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion in a 3-year-old child. J Pediatr Endocrinol Metab. 2011;24:219-222.
59. Markou A, Manning P, Kaya B, Datta SN, Bomanji JB, Conway GS. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome. Eur J Endocrinol. 2005;152: 521-525.
60. Machado MC, Sá SV, Goldbaum TS, et al. In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. J Endocrinol Invest. 2007;30:334-340.
61. Lutgers HL, Vergragt J, Dong PV, et al. Severe hypercortisolism: a medical emergency requiring urgent intervention. Crit Care Med. 2010;38:1598-1601.
62. de Matos LL, Trufelli DC, das Neves-Pereira JC, Danel C, Riquet M. Cushing's syndrome secondary to bronchopulmonary carcinoid tumor: report of two cases and literature review. Lung Cancer. 2006;53:381-386.
63. Luca PD, Oren A, Somers GR, Urbach SL. The search for ectopic ACTH production in a 9-year-old boy. J Pediatr Endocrinol Metab. 2013;26:781-783.
64. Lee T, Karl M, Solorzano CC. Adrenocorticotropic hormone-secreting pancreatic islet cell carcinoma. J Am Coll Surg. 2004;199: 336-337.
65. La Rosa S, Marando A, Ghezzi F, Colombo P, Finzi G, Capella C. Cushing's syndrome due to a pancreatic neuroendocrine tumor metastatic to the ovaries: a clinicopathological description of a case. Endocr Pathol. 2011;22:118-124.
66. Kumar J, Spring M, Carroll PV, Barrington SF, Powrie JK. 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin Endocrinol Oxf. 2006;64:371-374.
67. Kondo T, Matsuyama R, Ashihara H, et al. A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases. Endocr J. 2010;57:229-236.
68. Kenchaiah M, Hyer S. Cushing's syndrome due to ectopic ACTH from bronchial carcinoid: a case report and review. Case Rep Endocrinol. 2012;2012:215038.
69. Kishida K, MoriwakiM,MiyagawaJ, et al. Successful use of 111Inpentetrotide scintigraphy for localizing ectopic adrenocorticotropin-producing bronchial carcinoid tumor in a patient with Cushing's syndrome. Intern Med. 2003;42:996-1005.
70. Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phepentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab. 2004;89:2214-2221.
71. Iwata M, Oki Y, Okazawa T, et al. A rare case of adrenocorticotropic hormone (ACTH)-independent macroadrenal hyperplasia showing ectopic production of ACTH. Intern Med. 2012;51: 2181-2187.
72. Oh HC, Koh JM, Kim MS, et al. A case of ACTH-producing pheochromocytoma associated with pregnancy. Endocr J. 2003;50: 739-744.
73. Willenberg HS, Feldkamp J, Lehmann R, Schott M, Goretzki PE, ScherbaumWA.Acase of catecholamine and glucocorticoid excess syndrome due to a corticotropin-secreting paraganglioma.AnnNY Acad Sci. 2006;1073:52-58.
74. Hodish I, Giordano TJ, Starkman MN, Schteingart DE. Location of ectopic adrenocortical hormone-secreting tumors causing Cushing's syndrome in the paranasal sinuses. Head Neck. 2009;31: 699-706.
75. Hernández I, Espinosa-de-los-Monteros AL, Mendoza V, et al. Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor. Arch Med Res. 2006; 37:976-980.
76. Hashemzadeh S, Asvadi Kermani A, Ali-Asgharzadeh A, Halimi M, Soleimani M, Ladan A. Ectopic Cushing's syndrome secondary to pulmonary carcinoid tumor. Ann Thorac Surg. 2013;95:1797-1799.
77. Han JY, Mirsadraei L, Yeh MW, et al. Bilateral adrenalectomy: lifesaving procedure in severe Cushing syndrome. Endocr Pract. 2012;18:e85-e90.
78. Illyés G, Luczay A, Benyó G, et al. Cushing's syndrome in a child with pancreatic acinar cell carcinoma. Endocr Pathol. 2007;18: 95-102.
79. Grossrubatscher E, Vignati F, Dalino P, et al. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome. J Endocrinol Invest. 2005;28:72-78.
80. Grossman AB, Kelly P, Rockall A, Bhattacharya S, McNicol A, Barwick T. Cushing's syndrome caused by an occult source: difficulties in diagnosis and management. Nat Clin Pract Endocrinol Metab. 2006;2:642-647.
81. Gani LU, Gianatti EJ, Cheung AS, Jerums G, Macisaac RJ. Failure of functional imaging with gallium-68-DOTA-D-Phe1-Tyr3-octreotide positron emission tomography to localize the site of ectopic adrenocorticotropic hormone secretion: a case report. J Med Case Rep. 2011;5:405.
82. Gabalec F, Zavrelová A, Havel E, et al. Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome-a description of two cases. Acta Medica (Hradec Kralove). 2011;54: 127-130.
83. Uwaifo GI, Koch CA, Hirshberg B, et al. Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome? J Endocrinol Invest. 2003;26:710-717.
84. Arnaldi G, Mancini T, Kola B, et al. Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. J Clin Endocrinol Metab. 2003;88:5834-5840.
85. Corcuff JB, Deminiere C, Trouillas J, Puel O, Perel Y, Barat P. Ectopic Cushing's syndrome due to an adrenal ganglioneuroma. Horm Res Paediatr. 2010;73:405-408.
86. Fasshauer M, Lincke T, Witzigmann H, et al. Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer. 2006;6:108.
87. Farage M, Costa MA, Godoy-Matos AF. A rare case of Cushing syndrome by cyclic ectopic-ACTH. Arq Bras Endocrinol Metabol. 2012;56:324-330.
88. Esfahani AF, Chavoshi M, Noorani MH, et al. Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report. J Med Case Rep. 2010; 4:323.
89. El Zein M, Vali R, Charron M, Manson D, Perlman K, Shammas A. Neuroendocrine tumor in liver with positive ACTH receptor: a case report. J Pediatr Hematol Oncol. 2014;36:e1-e4.
90. Dutta R, Kumar A, Julka PK, et al. Thymic neuroendocrine tumour (carcinoid): clinicopathological features of four patients with different presentation. Interact Cardiovasc Thorac Surg. 2010;11: 732-736.
91. Doi M, Sugiyama T, Izumiyama H, Yoshimoto T, Hirata Y. Clinical features and management of ectopic ACTH syndrome at a single institute in Japan. Endocr J. 2010;57:1061-1069.
92. de Bruin C, Hofland LJ, Nieman LK, et al. Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion. J Clin Endocrinol Metab. 2012;97:455-462.
93. Därr R, Zöphel K, Eisenhofer G, et al. Combined use of 68Ga-DOTATATE and 18F-FDG PET/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome. J Clin Endocrinol Metab. 2012;97:2207-2208.
94. Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE. Octreoscan in patients with bronchial carcinoid tumours. Clin Endocrinol (Oxf). 2003;59:793-799.
95. Dahir KM, Gonzalez A, Revelo MP, Ahmed SR, Roberts JR, Blevins LS Jr. Ectopic adrenocorticotropic hormone hypersecretion due to a primary pulmonary paraganglioma. Endocr Pract. 2004;10:424-428.
96. Danilovic DL, Brando Neto RA, D'Abronzo H, Menezes MR, Lucon AM, Mendonca BB. Ectopic ACTH syndrome caused by pheochromocytoma: computed tomography-guided percutaneous ethanol injection as an alternative treatment. J Endocrinol Invest. 2007;30:780-786.
97. Corsello SM, Fintini D, LovicuRM,et al. EctopicACTHsyndrome due to occult bronchial carcinoid. Clin Nucl Med. 2009;34:459-461.
98. Cohade C, Broussaud S, Louiset E, Bennet A, Huyghe E, Caron P. Ectopic Cushing's syndrome due to a pheochromocytoma: a new case in the post-partum and review of literature. Gynecol Endocrinol. 2009;25:624-627.
99. Coe SG, Tan WW, Fox TP. Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life. J Gen Intern Med. 2008;23:875-878.
100. Chrisoulidou A, Pazaitou-Panayiotou K, Georgiou E, et al. Ectopic Cushing's syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma. Hormones (Athens). 2008;7:259-262.
101. Carrillo-Muñoz A, Onofre-Borja M, Borrego-Borrego R, Chávez-Mercado L, Navarro-Reynoso FP, Ibarra-Pérez C. Atypical intermediate-grade mediastinal carcinoid. Case presentation. Cir Cir. 2011;79:191-195.
102. Candrina R, Sleiman I, Zorzi F. ACTH-secreting pituitary adenoma within an ovarian teratoma. Eur J Intern Med. 2005;16: 359-360.
103. Burman P, Lethagen A, Ivancev K, Johansson L, Sundin A. Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling. Eur J Endocrinol. 2008;159:483-488.
104. Borrero CG, McCook B, Mountz JM. Indium-111 pentetreotide imaging of carcinoid tumor of the thymus. Clin Nucl Med. 2005; 30:218-221.
105. Bodelier AG, Groeneveld W, van der Linden AN, Haak HR. Symptomatic epidural lipomatosis in ectopic Cushing's syndrome. Eur J Endocrinol. 2004;151:765-769.
106. Koo BK, An JH, Jeon KH, et al. Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocr J. 2008;55:469-475.
107. Biering H, Pirlich M, Bauditz J, Sandrock D, Lochs H, Gerl H. PET scan in occult ectopic ACTH syndrome: a useful tool? Clin Endocrinol (Oxf). 2003;59:404-405.
108. Bernardi S, Grimaldi F, Finato N, et al.Apheochromocytoma with high adrenocorticotropic hormone and a silent lung nodule. Am J Med Sci. 2011;342:429-432.
109. Moraes AB, Taboada GF, Carneiro MP, et al. Utility of [(18)F] fluoro-2-deoxy-D: -glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors. Pituitary. 2009; 12:380-383.
110. Bansal M, Agarwal A, Govindarajan R. Ectopic adrenocorticotropic hormone syndrome due to a pancreatic neuroendocrine tumor [published online June 26, 2012]. J Gastrointest Cancer. doi: 10.1007/s12029-012-9400-7.
111. Ballav C, Naziat A, Mihai R, Karavitaki N, Ansorge O, Grossman AB. Mini-review: pheochromocytomas causing the ectopic ACTH syndrome. Endocrine. 2012;42:69-73.
112. Asha HS, Sudeep K, Alexander M, Korula A, Gnanamuthu BR, Thomas N. Cushing's syndrome in a case of thymic carcinoma. Indian J Endocrinol Metab. 2011;15:346-348.
113. Davi' MV, Salgarello M, Francia G. Positive (68)Ga-DOTATOCPET/CT after cortisol level control during ketoconazole treatment in a patient with liver metastases from a pancreatic neuroendocrine tumor and ectopic Cushing syndrome. Endocrine. 2015;49(2): 566-567.
114. Huang YT, Aziz SI, Ravi Kumar AS. Gallium-68 DOTA-TATE positron emission tomography/computed tomography: scintigraphic changes of adrenal glands following management of ectopic Cushing's syndrome by steroidogenesis inhibitors. World J Nucl Med. 2014;13:201-204.
115. Ghazi AA, Abbasi Dezfooli A, Amirbaigloo A, et al. Ectopic Cushing's syndrome secondary to lung and mediastinal tumours - report from a tertiary care centre in Iran. Endokrynol Pol. 2015;66:2-9.
116. Dubois S, Morel O, Rodien P, et al. A pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome. J Clin Endocrinol Metab. 2007;92:4512-4513.
117. Salvatori R, Fintini D, Westra WH, Cho SY, Schulick RD. Cushing's syndrome attributable to ectopic secretion of corticotropin in a patient with two neuroendocrine tumors. Endocr Pract. 2006; 12:656-659.
118. Thomas T, Zender S, Terkamp C, Jaeckel E, Manns MP. Hypercortisolaemia due to ectopic adrenocorticotropic hormone secretion by a nasal paraganglioma: a case report and review of the literature. BMC Res Notes. 2013;6:331.
119. Kakade HR, Kasaliwal R, Jagtap VS, et al. Ectopic ACTH-secreting syndrome: a single-center experience. Endocr Pract. 2013;19: 1007-1014.
120. Rindi G, Petrone G, Inzani F. The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction. Endocr Pathol. 2014;25:186-192.
121. Swearingen B, Katznelson L, Miller K, et al. Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab. 2004; 89:3752-3763.
122. Naswa N, Sharma P, Kumar A, et al. 68Ga-DOTANOCPET/CT in patients with carcinoma of unknown primary of neuroendocrine origin. Clin Nucl Med. 2012;37:245-251.
123. Koukouraki S, Strauss LG, Georgoulias V, EisenhutM,Haberkorn U, Dimitrakopoulou-Strauss A. Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging. 2006;33:1115-1122.
124. Caplin ME, Baudin E, Ferolla P, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids [published online February 2, 2015]. Ann Oncol. doi: 10.1093/annonc/mdv041.
125. Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012;61:6-32.
126. de Herder WW. GEP-NETS update: functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs). Eur J Endocrinol. 2014;170: R173-R183.
127. Toumpanakis C, Kim MK, Rinke A, et al. Combination of crosssectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology. 2014;99:63-74.
128. Bodei L, Sundin A, Kidd M, Prasad V, Modlin IM. The status of neuroendocrine tumor imaging: from darkness to light? Neuroendocrinology. 2015;101(1):1-17.
129. Koopmans KP, Glaudemans AW. Other PET tracers for neuroendocrine tumors. PET Clin. 2014;9:57-62.
130. Chuang CC, Bhurke S, Chen SY, Brulais S, Gabriel S. Clinical characteristics, treatment patterns, and economic burden in patients treated for neuroendocrine tumors in the United States: a retrospective cohort study. J Med Econ. 2015;18(2):126-136.
131. Isidori AM, Kaltsas GA, Mohammed S, et al. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 2003;88:5299-5306.
132. Woo YS, Isidori AM, Wat WZ, et al. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. J Clin Endocrinol Metab. 2005;90:4963-4969.
133. de Herder WW, Krenning EP, Malchoff CD, et al. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. AmJMed. 1994;96:305-312.
134. Lamberts SW, de Herder WW, Krenning EP, Reubi JC. A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome. J Clin Endocrinol Metab. 1994; 78:17-19.
135. Isidori AM, Graziadio C, Paragliola RM, et al. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens. 2015;33(1): 44-60.
136. Scillitani A, Mazziotti G, Di Somma C, et al. Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? Osteoporos Int. 2014;25:441-446.
137. Binderup T, Knigge U, Loft A, et al. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET. J Nucl Med. 2010;51:704-712.
138. Severi S, Nanni O, Bodei L, et al. Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours. Eur J NuclMedMolImaging. 2013; 40:881-888.
139. Rekhtman N. Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med. 2010;134:1628-1638.
140. Karageorgiadis AS, Papadakis GZ, Biro J, et al. Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone cosecreting tumors in children and adolescents causing Cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab. 2015;100(1):141-148.
141. Treglia G, Castaldi P, Rindi G, Giordano A, Rufini V. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine. 2012;42: 80-87.
142. Lococo F, Cesario A, Paci M, et al. PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol. 2014;35:8369-8377.
143. Sharma ST, Nieman LK. Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion. Eur J Endocrinol. 2012;166: 531-536.
144. Gentilin E, Tagliati F, Terzolo M, et al. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. J Endocrinol. 2013;218:275-285.
145. Donadille B, Groussin L, Waintrop C, et al. Management of Cushing's syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para'-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center. J Clin Endocrinol Metab. 2010; 95:537-544.
146. Bertagna X, Pivonello R, Fleseriu M, et al. LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study. J Clin Endocrinol Metab. 2014;99:1375-1383.
147. Ferone D, Pivonello C, Vitale G, Zatelli MC, Colao A, Pivonello R. Molecular basis of pharmacological therapy in Cushing's disease. Endocrine. 2014;46:181-198.